NIKKEI 225
26,393.04 -411.56 (-1.54%) HANG SENG
21,859.79 -137.10 (-0.62%) CRUDE OIL
105.83 +0.07 (+0.07%) GOLD FUTURES
1,806.20 -1.10 (-0.06%) DOW
30,775.43 -253.88 (-0.82%) BTC-GBP
15,534.69 -1,122.47 (-6.74%)
EVOTEC SE (EVT.BE)
- EQS Group
Evotec SE reports results of Annual General Meeting 2022
DGAP-News: Evotec SE / Key word(s): AGM/EGMEvotec SE reports results of Annual General Meeting 2022 22.06.2022 / 16:20 The issuer is solely responsible for the content of this announcement. ALL AGENDA ITEMS ADOPTED WITH THE REQUIRED MAJORITY CAMILLA MACAPILI LANGUILLE ELECTED AS NEW MEMBER OF THE SUPERVISORY BOARD; KASIM KUTAY RESIGNS FROM SUPERVISORY BOARD AUTHORISED CAPITAL 2022 RESOLVED REVISED REMUNERATION SYSTEM FOR MANAGEMENT BOARD APPROVEDHamburg, Germany, 22 June 2022:Evotec SE (Frankfur
- Zacks
Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J
Evotec (EVO) signs a collaboration agreement with Janssen, a wholly owned subsidiary of J&J, for discovering novel drugs in the field of protein homeostasis. Shares down.
- EQS Group
Evotec enters a drug discovery collaboration with Janssen
DGAP-News: Evotec SE / Key word(s): MiscellaneousEvotec enters a drug discovery collaboration with Janssen 14.06.2022 / 07:30 The issuer is solely responsible for the content of this announcement. STRATEGIC PARTNERSHIP LEVERAGES EVOTEC’S PROPRIETARY PLATFORM CAPABILITIES IN THE FIELD OF PROTEIN HOMEOSTASISHamburg, Germany, 14 June 2022:Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered a drug discovery collaboratio
